CDK9 inhibition appears to be an excellent target for epigenetic cancer therapy. Genes that have been epigenetically silenced by cancer can be reactivated by inhibiting CDK9, a DNA transcription regulator.
from Medindia Health News https://ift.tt/2Pncofe
No comments:
Post a Comment